Be part of the only event that brings together those prioritizing target discovery of ADCs at pharma, biotech and research institutes.
With 22+ hours of content, 2 interactive workshops and over 2 hours of networking with key industry leaders, this comprehensive forum will uniquely unite distinct ADC researchers focused on target selection in one setting to share lessons learned, case studies and advancements in the field.
Attend this focussed summit to learn from the field’s pioneers who’ll be sharing their experience and advances in:
|The target-payload pairing and ensuring this is 100% right from the get-go, leading to success in late-stage clinical trials and saving companies millions of dollars|
Defining the criteria of what makes a good target and going one step further into the differences with solid tumors and haematological cancer targets to break down the barrier and accelerate more solid tumour targeting ADCs into the clinic
Assessing the antibody for small molecule target validation and the time it takes to validate these targets so you can take new methods back to your teams to elevate your company’s target selection strategies